Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
about
Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila modelOn the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson's Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine.Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicityNetwork analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.(13)C metabolic flux analysis in neurons utilizing a model that accounts for hexose phosphate recycling within the pentose phosphate pathway.Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL/6 mice caused by chronic high-fat diet intake.Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.Drosophila Torsin Protein Regulates Motor Control and Stress Sensitivity and Forms a Complex with Fragile-X Mental Retardation ProteinAnalysis of Mitochondrial haemoglobin in Parkinson's disease brain.Rotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in ratsNew insights on the mitochondrial proteome plasticity in Parkinson's disease.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Mitochondrial control of cell bioenergetics in Parkinson's disease.Molecular changes in the postmortem parkinsonian brain.HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Brain metabolism in health, aging, and neurodegeneration.Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo.Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders3-Bromo-4,5-dihydroxybenzaldehyde Enhances the Level of Reduced Glutathione via the Nrf2-Mediated Pathway in Human KeratinocytesMeasuring glucose cerebral metabolism in the healthy mouse using hyperpolarized 13C magnetic resonance.Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.Purine metabolism gene deregulation in Parkinson's disease.Metabolomic Analysis Provides Insights on Paraquat-Induced Parkinson-Like Symptoms in Drosophila melanogaster.Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects.Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease.The Therapeutic Potential of Metformin in Neurodegenerative DiseasesComputational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression
P2860
Q28389710-F5845589-2916-4CB0-960B-9AFCAEA4A139Q33714263-6B264EED-3D05-4B6F-9EC9-7C6264F604ABQ34211654-405815A4-8FC9-4F03-9322-2C07533554CBQ34287243-3CF47ACF-27FB-4FF1-803F-0EE43A7DB9DAQ35129144-9451A6C2-891A-4916-81F2-F7D09DAAC652Q36604733-804D0A0B-FC12-40EB-A796-D4BCB2E72A6FQ36665054-A4E9E418-D72E-49D4-8112-7E2159BF6F52Q36913723-904186CC-2B68-450A-8FED-42314CAE81C2Q36996330-0ED03243-A633-4F35-8659-A440C170AD3FQ37083414-A772FA1A-FA9F-4072-858A-F3EE35956F7BQ37108659-8A157751-AE87-434D-AEED-604D275C92C6Q38452561-DCC37770-C74E-451E-92CE-FBFDE28F7D61Q38809233-598656BE-2082-4630-8BFC-B3933D108A76Q38811534-0C232610-F069-4E27-9D97-2D510F7D3A05Q38887346-9BBF694B-2CED-4308-9279-161CD6544E61Q39006663-4E7A07D2-4B75-4FCF-AB88-392B53762F63Q39199926-E551E12F-429D-4F3C-83AA-AAF63E7C1D6FQ39259780-59528A4F-793F-44F3-A71C-9A9CBB6D1637Q41197182-10DEA485-015A-436A-975A-E61CBCD8FD62Q41475139-83784DDC-8F2F-4C0C-9F21-F521ADA339A4Q41661850-D5256D07-7E2B-436D-9ACE-73A828D6C760Q41718228-FB1C7919-3BAC-4BB1-9E08-5A3C57D77D93Q41828813-DA7CE0B7-572C-4578-925D-71F50F6C9957Q48371760-A744CD47-BAD9-4A59-A14E-C10DE79A3FA7Q48445931-6ADDC432-FAC5-4487-95C1-DB7A5A3B1B7BQ50856979-09BAA938-0AE1-4721-8513-4E193D8955F6Q51691934-A9F835CC-9D3D-4B8A-8386-4945A2EB93F2Q52373049-CFAE9999-3AA7-46ED-978A-5F4430A4A450Q57175337-294F52BB-7850-4501-A83F-4130EE17A237Q58747839-971A12FE-087B-406F-A8AF-4099C67DA87A
P2860
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@en
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@nl
type
label
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@en
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@nl
prefLabel
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@en
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@nl
P2093
P2860
P921
P1476
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease.
@en
P2093
Adamantios Mamais
George Fg Allen
Helen Ling
Iain P Hargreaves
Janice L Holton
Kate E Duberley
Laura Dunn
Rina Bandopadhyay
Simon J Heales
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2013.11.001
P577
2013-11-09T00:00:00Z